Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 149
Titolo Data di pubblicazione Autore(i) File
New combinations with epirubicin in advanced breast cancer. 1-gen-2001 Conte, Pierfranco; Gennari, A; Landucci, E; Guarneri, Valentina; Donati, S; Salvadori, B; Bengala, C; Orlandini, C.
Rischio neoplastico post-trapianto 1-gen-2001 C., Bengala; Guarneri, Valentina; I., Pazzagli
Epirubicin/taxane combinations in breast cancer: experience from several Italian trials 1-gen-2001 Conte, Pierfranco; Gennari, A; Guarneri, Valentina; Landucci, E; Donati, S; Salvadori, B; Bengala, C; Orlandini, C; Baldini, E.
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC) 1-gen-2001 C., Bengala; I., Pazzagli; F., Innocenti; S., Donati; C., Favre; M. C., Menconi; F., Greco; R., Danesi; C., Orlandini; Guarneri, Valentina; M., Del Tacca; Conte, Pierfranco
Weekly docetaxel/paclitaxel in pretreated metalistic breast cancer 1-gen-2002 Gennari, A; Guarneri, Valentina; Landucci, E; Orlandini, C; Rondini, M; Salvadori, B; Ricci, S; Conte, Pierfranco
Outcomes of metastatic breast cancer patients older than 60 years treated with FEC or ET regimens: A retrospective analysis 1-gen-2003 A., Gennari; Guarneri, Valentina; C., Orlandini; B., Salvadori; S., Donati; M., Rondini; S., Ricci; E., Landucci; Conte, Pierfranco
High – dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study 1-gen-2003 C., Bengala; R., Danesi; Guarneri, Valentina; I., Pazzagli; S., Donati; C., Favre; S., Fogli; O., Biadi; F., Innocenti; M., DEL TACCA; M., Mariani; Conte, Pierfranco
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici 1-gen-2004 Dominici, Massimo; Guarneri, Valentina; Cafarelli, Luigi; Conte, Pierfranco
Safety of intravenous and oral bisphosphonates and compliance with dosing regimens 1-gen-2004 Conte, Pierfranco; Guarneri, Valentina
The curability of breast cancer and the treatment of advanced disease 1-gen-2004 Guarneri, Valentina; Conte, Pierfranco
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support 1-gen-2004 Guarneri, Valentina; C., Bengala; C., Orlandini; A., Gennari; S., Donati; D., Campani; P., Collecchi; M., Maur; Conte, Pierfranco
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy 1-gen-2004 A., Gennari; P., Bruzzi; C., Orlandini; B., Salvadori; S., Donati; E., Landucci; Guarneri, Valentina; M., Rondini; S., Ricci; Conte, Pierfranco
Changes in survival and time to progression in metastatic breast cancer (MBC) patients enrolled into clinical trials from 1983 to 2001 1-gen-2004 A., Gennari; Conte, Pierfranco; C., Orlandini; Guarneri, Valentina; R., Rosso; P., Bruzzi; for the North West Oncology Group, Gono
Renal safety of zoledronic acid in patients with bone metastases from breast cancer (BC) or other tumors treated with IV BisphosphonateS (BPS) for up to ten years 1-gen-2004 Guarneri, Valentina; Donati, S; Nicolini, M; Conte, Pierfranco
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma - Results from the Gruppo Oncologico Nord Ovest randomized trial 1-gen-2004 Conte, Pierfranco; Guarneri, Valentina; P., Bruzzi; T., Prochilo; B., Salvadori; A., Bolognesi; D., Aldrighetti; M., Venturini; R., Rosso; S., Mammoliti; F., Carnino; P., Giannessi; M., Costantini; A., Moyano; E., Baldini
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma 1-gen-2005 C., Bengala; Guarneri, Valentina; E., Giovannetti; M., Lencioni; E., Fontana; V., Mey; A., Fontana; U., Boggi; M., Del Chiaro; R., Danesi; S., Ricci; F., Mosca; M., Del Tacca; Conte, Pierfranco
In response to Body letter to the editor regarding "Safety of intravenous and oral Bisphosphonates and compliance with dosing regimens" 1-gen-2005 Conte, Pierfranco; Guarneri, Valentina
Predictive value of biological parameters for primary chemotherapy in operable breast cancer 1-gen-2005 A., Frassoldati; M., Maur; Guarneri, Valentina; M., Nicolini; Conte, Pierfranco
Operable Breast Cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation 1-gen-2005 Guarneri, Valentina; Frassoldati, A; Ficarra, G; Giovannelli, Simona; Borghi, F; Puglisi, F; Mansutti, M; Andreetta, C; Banna, G; Masci, G; Santoro, A; Boni, C; Bisagni, G; Michelotti, A; Crispino, S; Conte, Pierfranco
Prognostic value of pathologic complete response after primary chemotherapy in patients with hormone receptor-positive breast cancer. 1-gen-2005 Guarneri, Valentina; K., Broglio; S., Kau; M., Cristofanilli; Au, Buzdar; V., Valero; T., Buchholz; F., Meric; L., Middleton; Gn, Hortobagyi; AM Gonzalez, Angulo
Mostrati risultati da 1 a 20 di 149
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile